Peripheral Vascular Devices And Equipment Market Expansion Is Reshaping Competitive Dynamics Across The Industry
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
The peripheral vascular devices and equipment market is steadily evolving, driven by ongoing advancements in medical technology and increasing demand for effective vascular treatments. This sector is witnessing consistent growth, supported by demographic shifts and expanding healthcare infrastructure worldwide. Let’s explore the market’s current size, key growth drivers, segmentation, emerging trends, leading companies, and regional dynamics shaping its future.
Peripheral Vascular Devices And Equipment Market Size and Projected Revenue Growth
The market for peripheral vascular devices and equipment has shown steady growth over recent years. It is projected to increase from $10.29 billion in 2025 to $10.56 billion in 2026, representing a compound annual growth rate (CAGR) of 2.5%. This expansion during the historical period is largely due to the rising prevalence of peripheral artery disease, an aging population, the broadening scope of interventional cardiology, greater adoption of catheter-based therapies, and increased investment in hospital infrastructure.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2408&type=smp
Looking ahead, the market is expected to experience robust growth, reaching $13.15 billion by 2030 with a CAGR of 5.7%. This positive outlook stems from growing demand for minimally invasive vascular procedures, the rising use of bioresorbable materials, the expansion of outpatient vascular treatments, a stronger focus on precision-guided interventions, and continuous innovation in peripheral stent technologies. Key trends influencing the market include greater adoption of drug-coated vascular devices, increased use of minimally invasive endovascular techniques, rising demand for advanced atherectomy systems, the expansion of image-guided peripheral interventions, and an enhanced emphasis on long-term device patency.
Important Factors Fueling Growth in the Peripheral Vascular Devices Market
A primary driver for the peripheral vascular devices and equipment market is the rising healthcare expenditure worldwide. Healthcare expenditure — the total funds spent on healthcare goods and services by individuals, organizations, or governments — is increasing and enabling investments in advanced medical technologies. This financial commitment supports improved diagnosis and treatment of diseases such as peripheral artery disease, which in turn boosts demand for these devices.
Access The Complete Peripheral Vascular Devices And Equipment Market Report:
For example, in April 2025, the UK’s Office for National Statistics (ONS) reported that government-funded healthcare spending reached USD 2.91 billion (£258 billion) in 2024, marking a real-terms increase of 2.5% from the prior year. This growth in funding underscores stronger support for healthcare delivery and medical equipment acquisition, contributing significantly to market expansion.
Peripheral Vascular Devices and Equipment Market Categories and Segmentation
This market can be divided into several crucial segments:
1) By Type: Peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloons, catheters, PTA guide wires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters.
2) By Application: Treatment of peripheral blood vessel damage and treatment of peripheral blood vessel blockage.
3) By End User: Hospital and clinic applications.
Further subcategories include:
– Peripheral Vascular Stents: balloon-expandable stents and self-expanding stents.
– PTA Balloons: drug-coated balloons and non-drug-coated balloons.
– Catheters: diagnostic and therapeutic types.
– PTA Guide Wires: hydrophilic and non-hydrophilic guide wires.
– Atherectomy Devices: rotational, orbital, laser, and directional.
– Chronic Total Occlusion Devices: CTO crossing and CTO re-entry devices.
– Aortic Stents: self-expanding and balloon-expandable.
– Synthetic Surgical Grafts: polyester, polytetrafluoroethylene (PTFE), and dacron grafts.
– Embolic Protection Devices: distal and proximal protection devices.
– Inferior Vena Cava Filters: permanent and retrievable filters.
How Industry Developments Are Transforming Peripheral Vascular Device Demand
Leading companies in the peripheral vascular devices space are focusing on innovating larger-diameter catheters to improve interventions for peripheral artery disease. These catheters assist in fluid drainage or medication delivery and aim to enhance treatment outcomes.
For instance, in March 2023, Shockwave Medical Inc., a US medical device firm, introduced the peripheral intravascular lithotripsy (IVL) catheter. The Shockwave L6 Peripheral IVL catheter is specifically designed to modify calcified lesions in large peripheral arteries like the iliac and common femoral arteries. This targeted technology helps overcome complications commonly caused by artery calcification, which often reduces the success rates of standard endovascular treatments.
Key Players Competing in the Peripheral Vascular Devices and Equipment Market
Several prominent companies play a significant role in driving competition and innovation in this market, including:
Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cook Group, Angiomed GmbH & Co. Medizintechnik KG, Terumo Corporation, ENDOLOGIX Inc., Bolton Medical Inc., JOTEC GmbH, Clearstream Technologies, Aesculap AG, Curative Medical Devices, Lepu Medical Technology, MicroPort, Bioteque Corporation Co. Ltd., Cardinal Health, iVascular, B. Braun Group, Biosensors International Group, BIOTRONIK SE & Co., COVIDien, Volcano Corporation, AngioScore, Edwards Lifesciences Corporation, Cordis Corporation, Koninklijke Philips N.V., Nipro Corporation, Bluesail Medical Co. Ltd, Rex Medical, Teleflex Incorporated, Penumbra Inc., Lombard Medical Technologies PLC, W.L. Gore & Associates Inc., Merit Medical Systems Inc., Vascular Solutions Inc., LeMaitre Vascular Inc., and Spectranetics Corporation.
Geographical Overview of the Peripheral Vascular Devices Market Growth
In 2025, North America represented the largest segment of the global peripheral vascular devices and equipment market. Western Europe ranked as the second largest market. The analysis covers multiple regions including Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive picture of global demand and growth opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
